Burkina Faso vs Yemen: Number of people requiring preventive treatment for schistosomiasis
Burkina Faso
4.46 million people
in 2024
Yemen
3.85 million people
in 2024
Burkina Faso rank
19th
Yemen rank
21st
Number of people requiring preventive treatment for schistosomiasis over time
- Burkina Faso
- Yemen
How they compare
Burkina Faso currently reports 4.46 million people against 3.85 million people in Yemen, a difference of 613,160 people.
That makes Burkina Faso's figure about 1.2 times Yemen's.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Yemen ahead.
Burkina Faso ranks 19th and Yemen ranks 21st of 52 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million people | 6.08 million people | 2.21 million people | Yemen |
| 2020s | 3.48 million people | 3.75 million people | 272,092 people | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for schistosomiasis, Burkina Faso or Yemen?
- Burkina Faso, at 4.46 million people against 3.85 million people in Yemen as of 2024.
- What is the difference in number of people requiring preventive treatment for schistosomiasis between Burkina Faso and Yemen?
- 613,160 people, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Yemen?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Yemen rank globally for number of people requiring preventive treatment for schistosomiasis?
- Burkina Faso ranks 19th and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for schistosomiasis.